1 – 10 of 130
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Mitoxantrone alters CD24/Siglec-10 expression in malignant brain tumor models
- Contribution to journal › Article
-
Mark
Tumour acidosis remodels the glycocalyx to control lipid scavenging and ferroptosis
(2026) In Nature Cell Biology
- Contribution to journal › Article
- 2025
-
Mark
Complement Factor H Is an ICOS Ligand Modulating Tregs in the Glioma Microenvironment
- Contribution to journal › Article
-
Mark
Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression
- Contribution to journal › Article
-
Mark
Availability and use of PET in patients with brain tumours – a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey
- Contribution to journal › Article
-
Mark
Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype : study protocol for a randomized double-blind placebo-controlled trial
- Contribution to journal › Article
-
Mark
Noninvasive MGMT-promotor methylation prediction in high grade gliomas using conventional MRI and deep learning-based segmentations
- Contribution to journal › Article
- 2024
-
Mark
Decoding of the surfaceome and endocytome in primary glioblastoma cells identifies potential target antigens in the hypoxic tumor niche
- Contribution to journal › Article
-
Mark
Tumor suppressor role of the complement inhibitor CSMD1 and its role in TNF-induced neuroinflammation in gliomas
- Contribution to journal › Article
-
Mark
Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer
- Contribution to journal › Article
